BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy · Delayed Price · Currency is EUR 62.60
-1.68 (-2.61%)
At close: Dec 5, 2025
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of €12.2 billion as of December 5, 2025. Its market cap has increased by 203.22% in one year.
Market Cap
12.20B
Enterprise Value
13.25B
Revenue
301.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
€62.60
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from 2.92B to 12.20B, an increase of 317.66%. That is a compound annual growth rate of 24.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 12.20B | 143.53% |
| Dec 31, 2024 | 5.01B | -21.16% |
| Dec 29, 2023 | 6.35B | 496.14% |
| Dec 30, 2022 | 1.07B | -50.63% |
| Dec 31, 2021 | 2.16B | -69.70% |
| Dec 31, 2020 | 7.13B | 84.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 102.35B |
| Intesa Sanpaolo | 97.66B |
| Enel SpA | 88.39B |
| Ferrari | 60.35B |
| Assicurazioni Generali | 51.26B |
| Eni S.p.A. | 48.84B |
| Stellantis | 29.42B |
| Leonardo S.p.a. | 27.21B |